Podcasts about plwh

In this episode, Kathleen Page, MD, and Glenn J. Treisman, MD, PhD, discuss the interplay between addiction and HIV. Learn as they share their approaches to reframing the conversation about addiction and overcoming barriers to effective addiction care for people living with HIV.Presenters:Kathleen Page, MDProfessorInfectious DiseasesJohns Hopkins School of MedicineBaltimore, Maryland Glenn J. Treisman, MD, PhDEugene Meyer III Professor of Psychiatry and MedicineJohns Hopkins University School of MedicineBaltimore, MarylandDownloadable slides:https://bit.ly/3TR3OVVProgram:https://bit.ly/3WB2VCO

You can text us here with any comments, questions, or thoughts!We're thrilled to bring you an enlightening conversation with Kemi and Deepika Slawek. Dr. Slawek is an Associate Professor of Medicine at Montefiore Health Systems and Albert Einstein College of Medicine in Bronx, NY in the Division of General Internal Medicine. She is board certified in Infectious Diseases, Addiction Medicine, and Internal Medicine and is the Co-Director of the Montefiore Medical Cannabis Program. Dr. Slawek studies how to reduce morbidity and mortality in people with HIV (PWH) and people who use drugs (PWUD) using a harm reduction framework. She aims to study solutions for PWH and PWUD informed by her clinical experiences and patient's experiences. Dr. Slawek is the recipient of a K23 award from the National Institute on Drug Abuse to test how different formulations of medical cannabis effect neuropathic pain and inflammation in PLWH in an innovative quasi-experimental study. She is leading groundbreaking foundation-funded research to determine whether medical cannabis is effective in reducing opioid analgesic use in people with pain and is an alumnus of our Get That Grant® coaching program! In this episode, Dr. Slawek shares her passion for HIV research, the social justice aspects of her work, the transformative power of coaching and: The value of carving out time for self-reflection and understanding the "why" behind your actions. How stopping to evaluate your work can be challenging but ultimately leads to more effective and meaningful use of your time. The importance of aligning your daily tasks with your broader values and goals. How regularly taking the time to assess your work and its impact can keep you grounded and prevent burnout, especially when the world feels overwhelming. Loved this convo? Please go find Dr. Slawek on Twitter/X and LinkedIn and show her some love!  And if you'd like to learn more foundational career navigation concepts for women of color in academic medicine and public health, sign up for our KD Coaching Foundations Series: www.kemidoll.com/foundations.  REMINDER: Your Unapologetic Career Podcast now releases episode every other week! Can't wait that long? Be sure you are signed up for our newsletter (above) where there are NEW issues every month! 

In this episode, Tristan J. Barber, MA, MD, FRCP, and Glenn J. Treisman, MD, PhD, discuss the importance of screening, diagnosing, and treating PTSD in people with HIV. They illustrate their discussion through a patient case and provide strategies for accomplishing this, sharing their own experiences and approaches to thinking about PTSD, structuring appointments, and integrating care. Presenters:Tristan J. Barber, MA, MD, FRCPConsultant in HIV MedicineRoyal Free London NHS Foundation TrustHonorary Associate ProfessorInstitute for Global HealthUniversity College LondonLondon, United KingdomGlenn J. Treisman, MD, PhDEugene Meyer III Professor of Psychiatry and MedicineJohns Hopkins University School of MedicineBaltimore, MarylandDownloadable slides:https://bit.ly/4dBu929Program:https://bit.ly/3WB2VCO

In this episode, Bradley N. Gaynes, MD, MPH, and Glenn J. Treisman, MD, PhD, discuss the importance of screening, diagnosing, and treating depression in people living with HIV. They illustrate their discussion through a patient case and provide strategies for accomplishing this, including creation of a virtual network and employment of measurement-based care.Presenters:Bradley N. Gaynes, MD, MPHRay M. Hayworth, MD and Family Distinguished ProfessorProfessor of Psychiatry and EpidemiologyDirector, Division of Global Mental HealthCo-Director, Physician Scientist Training ProgramDepartment of PsychiatryUniversity of North Carolina School of MedicineChapel Hill, North CarolinaGlenn J. Treisman, MD, PhDEugene Meyer III Professor of Psychiatry and MedicineJohns Hopkins University School of MedicineBaltimore, MarylandDownloadable slides: https://bit.ly/3YgqqSOProgram: https://bit.ly/3WB2VCOTo get access to all of our new infectious disease podcast episodes, subscribe to the CCO infectious disease podcast channel on Apple Podcasts, Google Podcasts, or Spotify.  

Current ART regimens can successfully manage HIV infection in nearly all PLWH. But what happens when a patient with HIV is coinfected with a dangerous pathogen ART alone cannot handle? Two of the most common are hepatitis B and latent tuberculosis infection.Post-test for CME credits: https://elit.dkbmed.com/issues/203/test Hosted on Acast. See acast.com/privacy for more information.

We go to the gym, watch what we eat, many of us use condoms for safer sex experiences, yet one area we don't concern ourselves with  - so to speak is our butt health. Sure we know about prostate cancer and the such, but when was the last time you ask your Doctor about the health of your butt. Starting today, we make butt health a priority - and it has nothing to do with having sex with men. It actually has everything to do with a better understanding of how and what butt (anal) cancer is and how it starts, and what you can do to prevent it. Dr. Gary Bucher a leader in clinical care for all things anal and perianal precancerm talks candidly about what you should be doing to prevent cancer in your bum. In this episode we discuss: The high risk groups for anal cancer Practices you should implement to ensure you butt stays healthy The three leading screenings every man and woman should have to catch anal cancer early Bottoms up boys and let's talk about our butts! About Dr. Gary Bucher For over 35 years, Dr. Bucher has been a leader in clinical care and research with HIV/ AIDS patients. He has felt the need to be on the forefront of advances and care for PLWH. Dr. Bucher saw the rates of anal cancer increasing in PLWH, MSM and other high-risk groups. Dr. Bucher started referring patients for work up for abnormal anal pap smears (anal cytology) to colorectal surgeons. He soon found out that his patients were not getting the appropriate evaluation with high resolution anoscopy (HRA). His patients were examined with a rectal exam and a standard plain anoscopy. Subsequently, they were told that everything was normal when they could have had anal precancer that was not seen because an HRA was not performed. His patients felt a false sense of security that they were being evaluated properly and that all was normal. Dr. Bucher quickly found that evaluation and treatment of anal and perianal precancer were nonexistent in Chicago and decided he needed to learn how to perform HRA's and treat anal precancer. In 2008, Dr. Bucher was so concerned about the trajectory of anal disease in his community, that he started focusing exclusively on providing HRA and HPV related anal disease treatments and opened his Anal Dysplaisa Clinic MidWest (ADC MidWest) in Chicago. Dr. Bucher's experience continued to evolve with his clinical practice and research to the point where he was able to participate as the principal investigator in the largest anal cancer prevention study (ANCHOR Study) ever conducted in the USA. Dr. Bucher's private clinical practice enrolled 580 participants from the Chicagoland region out of the 4,446 total U.S. participants. The ANCHOR Study is an anal cancer prevention clinical trial funded by the National Institutes of Health (NIH) through the National Cancer Institute (NCI) and it's Office of HIV and AIDS Malignancy (OHAM) and AIDS Malignancy Consortium (AMC). Dr. Bucher has remained passionate about the the clinical advancements in the treatment of HPV related diseases. In 2020, Dr. Bucher began to develop a mentorship training program to prepare the next generation of providers in anal precancer screening and treatment. The multi-tiered preceptorship program officially launched in 2023 and is primed to fill a much needed gap in the growing need for providers who are proficient in HRA and HSIL treatments. Connect With Dr. Bucher Website Instagram Hey Guys, Check This Out! Are you a guy who keeps struggling to do that thing? You know the thing you keep telling yourself and others you're going to do, but never do? Then it's time to get real and figure out why. Join the 40 Plus: Gay Men Gay Talk, monthly chats. They happen the third Monday of each month at 5:00 pm...

Jürgen Rockstroh, MD - HIV and Hepatitis B: Managing Coinfections in PLWH

Jürgen Rockstroh, MD - HIV and Hepatitis B: Managing Coinfections in PLWH

Jürgen Rockstroh, MD - HIV and Hepatitis B: Managing Coinfections in PLWH

Jürgen Rockstroh, MD - HIV and Hepatitis B: Managing Coinfections in PLWH

Jürgen Rockstroh, MD - HIV and Hepatitis B: Managing Coinfections in PLWH

Jürgen Rockstroh, MD - HIV and Hepatitis B: Managing Coinfections in PLWH

Obtain Credit   |  View Activity Information…

Obtain Credit   |  View Activity Information…

In this episode, Nikos Dedes, Jeff Taylor, and Bernadette Sharp—people living with HIV—discuss how switching to long-acting ART has affected their quality of life. They are joined by 2 healthcare professionals—Iskandar Azwa,MBChB, MRCP, and Beng Eu, MBBS—who provide insights on how they assess and document health-related quality of life for their patients. The discussion focuses on personal experiences with how LA ART has improved health-related quality of life, including:Avoidance of drug–drug interactionsImproved confidentiality Decreased stigmaPresenters:Iskandar Azwa, MBChB, MRCPAssociate ProfessorInfectious DiseasesFaculty of MedicineUniversity of MalayaKuala Lumpur, MalaysiaNikos DedesPositive VoiceAthens, GreeceBeng Eu, MBBSDoctorPrahran Market Clinic Melbourne, Victoria, AustraliaBernadette SharpAdvocateJeff TaylorExecutive DirectorHIV+Aging Research ProjectPalm Springs, CaliforniaContent based on an online CME program supported by an independent educational grant from ViiV Healthcare.ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.Link to downloadable slides: https://bit.ly/488WwT7Link to full program: bit.ly/3EwEnRJ

In this episode, Iskandar Azwa, MBChB, MRCP; Nikos Dedes; Beng Eu, MBBS; Bernadette Sharp; and Jeff Taylor discuss challenges and opportunities with long-acting ART implementation, including:Personal experiences with receiving LA ART Views on long-acting ART in the development pipelinePerspectives on self-administration of LA ARTPresenters:Iskandar Azwa, MBChB, MRCPAssociate ProfessorInfectious DiseasesFaculty of MedicineUniversity of MalayaKuala Lumpur, MalaysiaNikos DedesPositive VoiceAthens, GreeceBeng Eu, MBBSDoctorPrahran Market Clinic  Melbourne, Victoria, AustraliaBernadette SharpAdvocateJeff TaylorExecutive DirectorHIV+Aging Research ProjectPalm Springs, CaliforniaContent based on an online CME program supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.Link to downloadable slides: https://clinicaloptions.com/CE-CME/infectious-disease/slides-fourth-90-and-la-art/17553-25368  Link to full program: https://bit.ly/3EwEnRJ

Go online to PeerView.com/JDT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses the factors that contribute to people living with HIV (PLWH) falling out of care, the barriers associated with different strategies for re-engaging PLWH, and individualized plans that can be used for re-engaging PLWH back into care. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care.

Go online to PeerView.com/JDT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses the factors that contribute to people living with HIV (PLWH) falling out of care, the barriers associated with different strategies for re-engaging PLWH, and individualized plans that can be used for re-engaging PLWH back into care. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care.

Go online to PeerView.com/JDT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses the factors that contribute to people living with HIV (PLWH) falling out of care, the barriers associated with different strategies for re-engaging PLWH, and individualized plans that can be used for re-engaging PLWH back into care. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care.

Go online to PeerView.com/JDT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses the factors that contribute to people living with HIV (PLWH) falling out of care, the barriers associated with different strategies for re-engaging PLWH, and individualized plans that can be used for re-engaging PLWH back into care. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care.

Go online to PeerView.com/JDT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses the factors that contribute to people living with HIV (PLWH) falling out of care, the barriers associated with different strategies for re-engaging PLWH, and individualized plans that can be used for re-engaging PLWH back into care. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care.

Go online to PeerView.com/JDT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert discusses the factors that contribute to people living with HIV (PLWH) falling out of care, the barriers associated with different strategies for re-engaging PLWH, and individualized plans that can be used for re-engaging PLWH back into care. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care.

Go online to PeerView.com/GRT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert provider, navigator, and two patients explore the factors that contribute to people living with HIV (PLWH) falling out of care and different strategies that can be used for re-engaging PLWH back into the HIV care continuum. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care

Go online to PeerView.com/GRT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert provider, navigator, and two patients explore the factors that contribute to people living with HIV (PLWH) falling out of care and different strategies that can be used for re-engaging PLWH back into the HIV care continuum. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care

Go online to PeerView.com/GRT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert provider, navigator, and two patients explore the factors that contribute to people living with HIV (PLWH) falling out of care and different strategies that can be used for re-engaging PLWH back into the HIV care continuum. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care

Go online to PeerView.com/GRT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert provider, navigator, and two patients explore the factors that contribute to people living with HIV (PLWH) falling out of care and different strategies that can be used for re-engaging PLWH back into the HIV care continuum. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care

Go online to PeerView.com/GRT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert provider, navigator, and two patients explore the factors that contribute to people living with HIV (PLWH) falling out of care and different strategies that can be used for re-engaging PLWH back into the HIV care continuum. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care

Go online to PeerView.com/GRT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert provider, navigator, and two patients explore the factors that contribute to people living with HIV (PLWH) falling out of care and different strategies that can be used for re-engaging PLWH back into the HIV care continuum. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care

Go online to PeerView.com/GRT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert provider, navigator, and two patients explore the factors that contribute to people living with HIV (PLWH) falling out of care and different strategies that can be used for re-engaging PLWH back into the HIV care continuum. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care

Go online to PeerView.com/GRT860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert provider, navigator, and two patients explore the factors that contribute to people living with HIV (PLWH) falling out of care and different strategies that can be used for re-engaging PLWH back into the HIV care continuum. Upon completion of this activity, participants should be better able to: Identify individual and structural factors that contribute to PLWH falling out of care; Discuss methodologies, benefits, and limitations associated with different strategies for re-engaging PLWH who are out of care; and Employ individualized and comprehensive plans to successfully re-engage PLWH in care

There has been a remarkable increase in the life expectancy of persons living with hemophilia (PLWH) over the past century, largely due to access to safe factor replacement products.  However, the course of progress has been uneven, and rocky, for many. This is part two of our series on Aging with Hemophilia. Contributors: William McKeown, MD Randall Curtis Gerry Dolan, MD, MBChB, FRCP, FRCPath Barbara Konkle, MD Sara L. Schwartz, PhD  Tam Perry, PhD   Senior Advisor: Donna DiMichele, MD   Hosted by: Patrick James Lynch   Show Notes: Presenting Sponsor: Sanofi   Subscribe to the Global Hemophilia Report   Connect with the Global Hemophilia Report Global Hemophilia Report on LinkedIn Global Hemophilia Report on Twitter Global Hemophilia Report on Facebook   Connect with BloodStream Media: BloodStreamMedia.com BloodStream on Facebook  BloodStream on Twitter   

There has been a remarkable increase in the life expectancy of persons living with hemophilia (PLWH) over the past century, largely due to access to safe factor replacement products.  However, the course of progress has been uneven, and rocky, for many.   Contributors: William McKeown, MD Randall Curtis Gerry Dolan, MD, MBChB, FRCP, FRCPath Barbara Konkle, MD   Senior Advisor: Donna DiMichele, MD   Hosted by: Patrick James Lynch   Listen to Blood of the Paladin Podcast   Show Notes: Presenting Sponsor: Sanofi   Subscribe to the Global Hemophilia Report Listen to BloodStream's Journey to Joint Health episode.   Connect with the Global Hemophilia Report Global Hemophilia Report on LinkedIn Global Hemophilia Report on Twitter Global Hemophilia Report on Facebook   Connect with BloodStream Media: BloodStreamMedia.com BloodStream on Facebook  BloodStream on Twitter 

In this episode, Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD​, discusses strategies for and importance of HIV care engagement and reengagement for those who have fallen out of care. Her overview includes:WHO Global Health Strategy on HIVLongitudinal HIV care trajectoriesPromotion of successful care and antiretroviral therapy (ART) adherenceDifferentiated service deliveryImproving care and ART adherence in high-risk groupsPatient perspectives on ART persistence Presenter:Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD​Director​Desmond Tutu HIV Centre​Past President​International AIDS Society​Faculty of Health Sciences​University of Cape TownCape Town, South Africa​Panelists:Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD​Chief and DirectorVHS-Infectious Diseases Medical Centre​DirectorChennai Antiviral Research and Treatment (CART) Clinical Research Site​Voluntary Health Services​Chennai, IndiaChloe Orkin, MBChB, FRCP, MD​Professor of HIVQueen Mary, University of London​Consultant Physician​Lead for HIV ResearchBarts Health NHS Trust​The Royal London Hospital​London, United Kingdom​Babafemi Taiwo, MBBS​Gene Stollerman Professor of Medicine​Chief, Division of Infectious Diseases​Northwestern University Feinberg School of Medicine​Chicago, IllinoisContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Follow along with the slides: https://bit.ly/3dSNoumLink to full program:https://bit.ly/3AE2AV1

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?

Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?

Most people living with HIV gain weight when initiating ART. For some, the weight gain signifies a “return to health”; for others, the additional weight can be clinically significant and may be strongly associated with an increased risk of metabolic abnormalities. What causes this weight gain? How can patients most at risk for weight-related comorbidities be identified? Join us as we discuss these and other issues with Dr. Todd Brown, Professor of Medicine and Epidemiology at Johns Hopkins University, in this eHIV Review podcast. Take our post-test to claim CME credits.To read a companion newsletter click here. Our GDPR privacy policy was updated on August 8, 2022. Visit acast.com/privacy for more information.

In this episode, Babafemi Taiwo, MBBS, discusses strategies for reaching people with HIV who are not yet diagnosed. His overview includes:HIV diagnosis by global regionDisparities in serostatus awarenessPatient perspective on importance of HIV testingBarriers to HIV diagnosisComplications from late HIV diagnosisStrategies to improve rates of HIV testingPresenter:Babafemi Taiwo, MBBS​Gene Stollerman Professor of Medicine​Chief, Division of Infectious Diseases​Northwestern UniversityFeinberg School of Medicine​Chicago, IllinoisPanelists:Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhDDirectorDesmond Tutu HIV Centre​Past PresidentInternational AIDS Society​Faculty of Health SciencesUniversity of Cape TownCape Town, South Africa​Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD​Chief and DirectorVHS Infectious Diseases Medical Centre​Director, Chennai Antiviral Research and Treatment (CART) Clinical Research Site​Voluntary Health Services​Chennai, IndiaChloe Orkin, MBChB, FRCP, MDProfessor of HIVQueen Mary, University of London​Consultant Physician​Lead for HIV ResearchBarts Health NHS Trust​The Royal London Hospital​London, United Kingdom​Content based on an online CME program supported by an independent educational grant from Gilead Sciences.Follow along with the slides: https://bit.ly/3PJRthDLink to full program:https://bit.ly/3AE2AV1

In this episode, Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD, discusses the importance of linking people to care after a positive HIV diagnosis. His overview includes:HIV care continuumFactors that delay linkage to careOrganized strategies to improve linkage to care for people with HIVInterventions that may improve linkage to care for people with HIVPatient perspective on how to engage patients in their HIV care Presenter:Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD​Chief and DirectorVHS Infectious Diseases Medical Centre​Director, Chennai Antiviral Research and Treatment (CART) Clinical Research Site​Voluntary Health Services​Chennai, IndiaPanelists:Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD​Director​Desmond Tutu HIV Centre​Past President​International AIDS Society​Faculty of Health Sciences​University of Cape TownCape Town, South Africa​Chloe Orkin, MBChB, FRCP, MD​Professor of HIVQueen Mary, University of London​Consultant Physician​Lead for HIV ResearchBarts Health NHS Trust​The Royal London Hospital​London, United Kingdom​Content based on an online CME program supported by an independent educational grant from Gilead Sciences.Follow along with the slides: https://bit.ly/3PJ4iJ8Link to full program:https://bit.ly/3AE2AV1

In this episode, Chloe Orkin, MBChB, FRCP, MD​, discusses strategies for successful antiretroviral therapy (ART) initiation. Her overview includes:Recommendations for rapid ARTFirst-line ART regimens for treatment-naive people with HIVIMEA 055 FAST studySTAT studyDIAMOND studyAntiretroviral resistance mutationsPatient perspectives on the importance of rapid ART initiationPresenter:Chloe Orkin, MBChB, FRCP, MDProfessor of HIVQueen Mary, University of London​Consultant Physician​Lead for HIV ResearchBarts Health NHS Trust​The Royal London Hospital​London, United Kingdom​Panelists:Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD​DirectorDesmond Tutu HIV Centre​Past PresidentInternational AIDS Society​Faculty of Health SciencesUniversity of Cape TownCape Town, South Africa​Nagalingeswaran Kumarasamy, MBBS, FRCP, PhD​Chief and DirectorVHS Infectious Diseases Medical Centre​Director, Chennai Antiviral Research and Treatment (CART) Clinical Research Site​Voluntary Health Services​Chennai, IndiaBabafemi Taiwo, MBBS​Gene Stollerman Professor of Medicine​Chief, Division of Infectious Diseases​Northwestern UniversityFeinberg School of Medicine​Chicago, IllinoisContent based on an online CME program supported by an independent educational grant from Gilead Sciences.Follow along with the slides: https://bit.ly/3dSNoumLink to full program:https://bit.ly/3AE2AV1

Are PLWH at higher risk for increased mortality from COVID-19 infection? How important is it for PWLH to get vaccinated and boosted? Is breakthrough COVID-19 infection more likely to occur among PLWH? What about “long COVID” (PASC)?Join Clinical Research Nurse Diane Kanjilal, manager of the Infectious Disease Clinical Research Unit at Massachusetts General Hospital, as we discuss these questions in this eHIV Review podcast.Take our post-test to claim CME credits.To read a companion newsletter click here. See acast.com/privacy for privacy and opt-out information.

This week on Pharm 5: Medicare Part D overpaying by $3.6B vs. Mark Cuban Vaxneuvance Pneumococcal-15 for kids Healthcare Implications from Biden's LGBTQI+ Executive Order ANCHOR Study reduces progression to anal cancer by 57% in PLWH and HSIL ADVANCE Study enrollment open for MSM interested in donating blood References: Lalani HS, Kesselheim AS, Rome BN. Potential medicare part D savings on generic drugs from the Mark Cuban Cost Plus Drug Company. Annals of Internal Medicine. 2022. doi:10.7326/m22-0756 Merck & Co., Inc. U.S. FDA Approves Merck's VAXNEUVANCETM (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Infants and Children. Merck.com. https://bit.ly/3tXVlDL. Published June 22, 2022. Accessed June 23, 2022. Fact sheet: President Biden to Sign Historic Executive Order advancing LGBTQI+ equality during Pride Month. The White House. https://bit.ly/3yfS6Kf. Published June 15, 2022. Accessed June 23, 2022. Palefsky JM, Lee JY, Jay N, et al. Treatment of anal high-grade squamous intraepithelial lesions to prevent anal cancer. New England Journal of Medicine. 2022;386(24):2273-2282. doi:10.1056/nejmoa2201048 Advance study. https://bit.ly/3Nbzu2p. Accessed June 23, 2022.

In this episode, Yvette Raphael provides her perspectives and advice as an individual living with HIV in South Africa for more than 20 years. She shares her experiences and ideas for how to improve processes related to HIV diagnosis, care linkage, and treatment.Presenter:Yvette RaphaelContent based on an online CME program supported by an independent educational grant from Gilead Sciences, Inc.Link to full program: https://bit.ly/3tmgozy

This week we're back for a quick round-up with John Faragon to talk about the use of two medications to treat HIV – islatravir and doravirine. Find out what they are, what they do, and how they can help you as a provider improve treatment for PLWH. --Help us track the number of listeners our episode gets by filling out this brief form! 

Happy New Year! We're kicking off our 2022 podcast season with an update on HIV stats from the CDC. We break it all down with John Faragon so that you as providers can know what these new numbers mean and how they affect PLWH. --Help us track the number of listeners our episode gets by filling out this brief form! 

Neste episódio abordamos as complicações neurológicas mais frequentes na população com infecção VIH estabilizada a longo prazo: doença vascular cerebral, deterioração cognitiva, epilepsia e neuropatia periférica. Nesta população o envelhecimento representa um importante factor de risco para o surgimento destas complicações. O Dr João Massano aborda aspectos importantes do diagnóstico, tratamento e referenciação dos doentes afectados.Dr. João MassanoMédico Neurologista Centro Hospitalar Universitário de São João E.P.E.; Faculdade de Medicina da Universidade do Porto Dra. Ana Rita SilvaMédica Infeciologista do Hospital Beatriz AngeloOlho Clínico é um Podcast da MSD de atualização científica, direcionado exclusivamente a Profissionais de Saúde. O conteúdo do mesmo não tem por objetivo induzir qualquer alteração de comportamento na prescrição ou toma de medicamentos.  PT-NON-01044 06/2021

Hoje conversamos sobre a saúde e a doença mental na população que vive com VIH.Da comorbilidade ao duplo diagnóstico, dos antirretrovíricos aos psicofármacos. Ficou curioso? Ouça tudo num dos nossos canais!Prof. Dr. Miguel BragançaMédico Psiquiátra Centro Hospitalar Universitário de São João E.P.E.; Faculdade de Medicina da Universidade do Porto Dra. Ana Rita SilvaMédica Infeciologista do Hospital Beatriz AngeloOlho Clínico é um Podcast da MSD de atualização científica, direcionado exclusivamente a Profissionais de Saúde. O conteúdo do mesmo não tem por objetivo induzir qualquer alteração de comportamento na prescrição ou toma de medicamentos. PT-NON-01043  06/2021